Weighted Average Number of Shares Outstanding, Basic of AVAI BIO, INC. from 31 Mar 2021 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
AVAI BIO, INC. quarterly and annual Weighted Average Number of Shares Outstanding, Basic in shares history and change rate from 31 Mar 2021 to 31 Dec 2025.
  • AVAI BIO, INC. Weighted Average Number of Shares Outstanding, Basic for the quarter ending 31 Dec 2025 was 138,029,337, a 0.75% increase year-over-year.
  • AVAI BIO, INC. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 128,148,099, a 48% increase from 2023.
  • AVAI BIO, INC. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 86,532,015, a 125% increase from 2022.
  • AVAI BIO, INC. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 38,503,811, a 46% increase from 2021.
Source SEC data
View on sec.gov
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Change (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Change (%)

AVAI BIO, INC. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q4 2025 138,029,337 +1,024,702 +0.75% 01 Oct 2025 31 Dec 2025 10-Q 12 Feb 2026 2026 Q3
Q3 2025 137,624,709 +14,020,478 +11% 01 Jul 2025 30 Sep 2025 10-Q 14 Nov 2025 2026 Q2
Q2 2025 137,462,534 +21,634,934 +19% 01 Apr 2025 30 Jun 2025 10-Q 12 Aug 2025 2026 Q1
Q1 2025 128,148,099 +41,616,084 +48% 01 Jan 2025 31 Mar 2025 10-K 08 Jul 2025 2025 FY
Q4 2024 137,004,635 +62,163,898 +83% 01 Oct 2024 31 Dec 2024 10-Q 12 Feb 2026 2026 Q3
Q3 2024 123,604,231 +49,337,177 +66% 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2025 2026 Q2
Q2 2024 115,827,600 +58,180,932 +101% 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2025 2026 Q1
Q1 2024 86,532,015 +48,028,204 +125% 01 Jan 2024 31 Mar 2024 10-K 08 Jul 2025 2025 FY
Q4 2023 74,840,737 +42,609,654 +132% 01 Oct 2023 31 Dec 2023 10-Q 07 Feb 2025 2025 Q3
Q3 2023 74,267,054 +42,035,971 +130% 01 Jul 2023 30 Sep 2023 10-Q/A 21 Jan 2025 2025 Q2
Q2 2023 57,646,668 +31,330,585 +119% 01 Apr 2023 30 Jun 2023 10-Q/A 21 Jan 2025 2025 Q1
Q1 2023 38,503,811 +12,187,728 +46% 01 Jan 2023 31 Mar 2023 10-K/A 19 Feb 2025 2024 FY
Q4 2022 32,231,083 +5,915,000 +22% 01 Oct 2022 31 Dec 2022 10-Q 14 Feb 2024 2024 Q3
Q3 2022 32,231,083 +5,949,483 +23% 01 Jul 2022 30 Sep 2022 10-Q 17 Nov 2023 2024 Q2
Q2 2022 26,316,083 +34,483 +0.13% 01 Apr 2022 30 Jun 2022 10-Q 16 Aug 2023 2023 Q1
Q1 2022 26,316,083 01 Jan 2022 31 Mar 2022 10-K/A 13 Jul 2023 2022 FY
Q4 2021 26,316,083 01 Oct 2021 31 Dec 2021 10-Q 14 Feb 2023 2023 Q3
Q3 2021 26,281,600 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2022 2023 Q2
Q2 2021 26,281,600 01 Apr 2021 30 Jun 2021 10-Q 19 Aug 2022 2023 Q1

AVAI BIO, INC. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 128,148,099 +41,616,084 +48% 01 Apr 2024 31 Mar 2025 10-K 08 Jul 2025 2025 FY
2023 86,532,015 +48,028,204 +125% 01 Apr 2023 31 Mar 2024 10-K 08 Jul 2025 2025 FY
2022 38,503,811 +12,187,728 +46% 01 Apr 2022 31 Mar 2023 10-K/A 19 Feb 2025 2024 FY
2021 26,316,083 +34,483 +0.13% 01 Apr 2021 31 Mar 2022 10-K/A 13 Jul 2023 2022 FY
2020 26,281,600 01 Apr 2020 31 Mar 2021 10-K 29 Jun 2022 2022 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.